drugset / Trial / NCT03660293

Prediction and Prevention of Asymptomatic Cardiovascular Insult in Type 1 Diabetic Children: Comparative Effectiveness of Cardioprotective Drugs

NCT03660293

Completed 150 enrolled Tanta University
RandomizedParallel-groupDouble-blindPrevention

Summary

Diabetic cardiomyopathy (DCM) is a distinct clinical entity of diabetic heart muscle that describes diabetes associated changes in the structure and function of the myocardium in the absence of coronary artery disease, hypertension, and valvular disease. Oxidative stress plays a critical role in DCM development. DCM can be diagnosed using the novel methods of echocardiography (tissue Doppler imaging, Speckling tracking techniques and more recent real time 4D echocardiography). There is a possible cardioprotective effect of statins, Captopril and L-Carnitine in type 1 diabetic children and adolescents.

Timeline

Start
2017-04-01
Primary completion
2019-06-01
Completion
2019-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 2 mg/kg
Subject Captopril Small molecule 0.2 mg/kg
Subject L-carnitine Other / unclassified 50 mg/kg